HEALTHEQUITY, INC. (HQY) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001428336 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jul 31, 2026 | Aug 27, 2026 | $350.7M | $65.6M | $0.78 | Filing |
| Apr 30, 2026 | May 28, 2026 | $354.6M | $69.4M | $0.82 | Filing |
| Jan 31, 2026 | Feb 17, 2026 | $334.6M | $49.7M | $0.58 | Filing |
| Oct 31, 2025 | Dec 3, 2025 | $322.2M | $51.7M | $0.59 | Filing |
| Jul 31, 2025 | Sep 2, 2025 | $325.8M | $59.9M | $0.68 | Filing |
| Apr 30, 2025 | Jun 3, 2025 | $330.8M | $53.9M | $0.61 | Filing |
| Jan 31, 2025 | Feb 18, 2025 | $311.8M | $26.4M | $0.30 | Filing |
| Oct 31, 2024 | Dec 9, 2024 | $300.4M | $5.7M | $0.06 | Filing |
What would HEALTHEQUITY, INC. have to report for its valuation to change?
At $92.03, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 23.2% a year, to $7.87. On that path the next quarter needs diluted EPS near $0.73, against $0.59 in the quarter ended Oct 31, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 23.2% | 23.2% |
| EPS needed in final year | $7.87 | $7.87 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. HQY goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.